The effect of doxycycline on live birth rates in women with chronic endometritis suffering from recurrent miscarriage
Recurrent miscarriage is heartbreaking, and doctors often cannot find a clear cause. One possible explanation is chronic endometritis, which is a mild, long-term swelling or irritation in the lining of the womb caused by an imbalance of bacteria. While some private clinics already offer antibiotics for this, there is no solid scientific evidence proving that it helps women have a healthy baby. The CERM trial, run by the University of Warwick, investigates whether taking an antibiotic called doxycycline before getting pregnant improves birth rates. Women aged 18 to 41 with two or more unexplained early miscarriages first have a small biopsy to check their womb lining. If inflammation is found, they are randomly chosen to take either a short course of doxycycline or dummy capsules (placebos) before trying to get pregnant again.
At a glance
What is this study about?
A healthy womb lining is crucial for an embryo to attach and grow safely into a baby. Sometimes, common bacteria in the womb become unbalanced, leading to a gentle, long-lasting irritation known as chronic endometritis. Because this inflammation rarely causes noticeable symptoms or pain, many women never realise they have it, even though it may be linked to repeated miscarriages.
Currently, some private clinics prescribe antibiotics to clear this swelling, but doctors do not yet have firm scientific proof that it leads to more live births. The CERM study was designed to answer this question fairly. By running a carefully monitored trial, researchers can learn whether this treatment really works or if it makes no difference to pregnancy outcomes.
Taking part helps medical experts understand how the womb environment affects pregnancy. If the antibiotic proves effective, it could lead to new, standard NHS treatments that help more women carry a baby to term, potentially sparing many families the heartbreak of recurrent miscarriage.
Key takeaways
- The trial tests whether the antibiotic doxycycline improves birth rates in women with repeated miscarriages.
- Open to women aged 18 to 41 who have had two or more consecutive, unexplained early miscarriages.
- Requires a womb lining biopsy to check for signs of chronic inflammation.
- Women with inflammation receive either doxycycline capsules or dummy capsules at random.
- You must use condoms to avoid pregnancy for roughly three months during testing and treatment.
Who may be eligible?
You may be able to join this study if you are a woman aged between 18 and 41 who has had two or more consecutive early miscarriages (during the first three months of pregnancy) with no clear medical cause found. Your natural menstrual cycle should also be fairly regular, typically lasting between 21 and 42 days.
You will not be able to take part if you have a known, treatable reason for your miscarriages, such as a thyroid disorder, a blood-clotting condition, or an unusually shaped womb. You are also not eligible if you are currently pregnant, breastfeeding, allergic to doxycycline, taking long-term antibiotics, or living with conditions like severe liver problems, lupus, or poorly controlled diabetes.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you a woman aged between 18 and 41?
- Have you had two or more early miscarriages in a row?
- Have standard medical tests failed to find a cause for your miscarriages?
- Are your periods generally regular (lasting between 21 and 42 days)?
- Are you willing to use condoms to pause trying for a baby for about three months?
- Are you free from severe liver problems, lupus, and doxycycline allergies?
What does participation involve?
Your participation begins with a screening visit where a doctor takes a small tissue sample (a biopsy) from your womb lining to look for inflammation. While preparing for the biopsy and waiting for results, you must use barrier contraception (such as condoms) to avoid getting pregnant.
If the biopsy shows no inflammation, you will not receive study medication, but the team will check in with you every three months for up to a year to see if you have become pregnant. If inflammation is present, a computer will randomly assign you to take either doxycycline capsules or matching dummy capsules (placebo) for a short course.
Once your treatment finishes and you have had your next period, you can start trying to conceive. The research team will contact you every three months to check on your progress. If you give birth, they will collect outcome information and check in on you around eight weeks after your baby arrives.
Potential risks and benefits
Locations (31)
- Walsgrave General HospitalCity onlyCoventry, England
- John Radcliffe HospitalApproximateOxford, England
- Liverpool Womens HospitalCity onlyLiverpool, England
- Burnley General HospitalApproximateBurnley, England
- Worthing HospitalApproximateWorthing, England
- St Richard's HospitalApproximateChichester, England
- Singleton HospitalApproximateSwansea, Wales
- The James Cook University HospitalApproximateMiddlesbrough, England
- Royal United HospitalApproximateBath, England
- Ipswich HospitalApproximateIpswich, England
- Darlington Memorial HospitalUnverifiedDarlington, England
- University Hospital of North DurhamUnverifiedDurham, England
Common questions
What is chronic endometritis?
It is a mild, ongoing swelling of the womb lining, usually caused by a harmless bacterial imbalance. It rarely causes symptoms but may interfere with how an embryo attaches.
What is a placebo?
A placebo is a dummy pill that looks and tastes identical to the real medication but contains no active ingredients. It helps scientists see if the real medicine actually works.
Can I choose whether I get the antibiotic?
No. A computer allocates participants at random to either the antibiotic or the dummy pill so that the trial results remain unbiased and scientifically valid.
Is the womb biopsy painful?
Most women experience brief cramping similar to period pain during the biopsy, and you might notice light spotting afterwards. These symptoms usually settle quickly.
Why must I avoid pregnancy at the start of the study?
You need to pause trying for a baby using condoms for roughly three months to protect any potential pregnancy while having the biopsy and taking the trial medication.
How to find out more
Kimberley Stewart
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.